One Scientific Breakthrough Can Change Countless Lives
In pursuit of the impossible
We believe in helping people who are struggling with serious and debilitating diseases.
Learn More About UsBuilding on 300 years of innovation, MTPA is where progressive diseases are met with real progress. We proudly carry the torch—lighting the way toward advancements that make a meaningful difference in the lives of people living with debilitating diseases.
Unmet Needs
Every day we tackle tough challenges in science and medicine. Our teams work diligently to develop smart options that will enable healthcare providers to offer safe and effective treatments for devastating illnesses.
Many people living with amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD) have unmet medical needs. We are committed to doing our best to find solutions that may help address those needs.
We’re proud to support the communities we serve and are dedicated to ensuring their needs are met—whether we’re providing support, partnering with advocacy or sharing powerful stories of resilience.
Registration of Clinical Trial Information and Disclosure of Results
a. Registration of our clinical trial information, and disclosure of results, to clinical trial registries
MTPA will register and disclose information on publicly accessible clinical trial registries such as ClinicalTrials.gov regarding clinical trials that are being conducted or have been conducted.
b. Disclosure of clinical trial summary results
MTPA will disclose the results from clinical trials in patients that form part of the submission package for products approved in the United States. Results will not be disclosed if MTPA decides that disclosure may lead to identification of clinical trial participants. Results may not be disclosed under any of the following conditions:
- A third party, such as a company involved in joint development, has not agreed to disclosure.
- Disclosure may interfere with publication in medical journals.
- Disclosure may interfere with the protection of intellectual property rights.